Aclidinium/formoterol

Aclidinium/formoterol
Combination of
Aclidinium bromide	Long-acting muscarinic antagonist
Formoterol	Long-acting β₂ agonist
Clinical data
Trade names	Brimica Genuair, Duaklir Genuair
AHFS/Drugs.com	UK Drug Information
Routes of administration	Inhalation
ATC code	R03AL05 (WHO)
Legal status
Legal status	℞ (Prescription only)
Identifiers
CAS Number	870244-45-4

Aclidinium/formoterol (trade names Duaklir and Brimica) is a combination drug for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β₂ agonist.^[1]

References

Short-acting β₂ agonists	Bitolterol Carbuterol Fenoterol Isoetarine Pirbuterol Procaterol Reproterol Rimiterol Salbutamol (albuterol)^#/Levosalbutamol (levalbuterol) Terbutaline Tulobuterol

Long-acting β₂ agonists	Bambuterol Clenbuterol Formoterol/Arformoterol Salmeterol Salmefamol

Ultra-long-acting β₂ agonists	Abediterol Carmoterol Indacaterol Olodaterol Vilanterol

Other	Epinephrine^# Hexoprenaline Isoprenaline (isoproterenol) Orciprenaline (metaproterenol)

Eicosanoid inhibition

Leukotriene antagonists	Montelukast Pranlukast Zafirlukast

Arachidonate 5-lipoxygenase inhibitors	Zileuton

Thromboxane receptor antagonists	Ramatroban Seratrodast

Non-xanthine PDE4 inhibitors	Ibudilast Roflumilast

Others/unknown

Combination products

This article is issued from Wikipedia - version of the 9/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.